UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

Texting to Improve Adherence in HIV+ With Bipolar Disorder

Not Applicable

Completed

Conditions: HIV Disease
Bipolar Disorder

Interventions: Behavioral: Psychoeducation
Behavioral: individualized Texting for Adherence Building (iTAB)

First Posted Date: 2014-03-18

Last Posted Date: 2021-08-27

Lead Sponsor: University of California, San Diego

Target Recruit Count: 58

Registration Number: NCT02090634

Locations: 🇺🇸
HIV Neurobehavioral Research Program (HNRP), Department of Psychiatry, Univeristy of California, San Diego, California, United States

Problem Solving Therapy for Prostate Cancer Spousal Caregivers

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Behavioral: Problem-Solving Therapy

First Posted Date: 2014-03-12

Last Posted Date: 2020-03-05

Lead Sponsor: University of California, San Diego

Target Recruit Count: 338

Registration Number: NCT02085096

Locations: 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States

Clinical Trials Education Program for Hispanic Americans

Phase 3

Completed

Conditions: Cancer

Interventions: Behavioral: Cancer Clinical Trials Education Program

First Posted Date: 2014-03-11

Last Posted Date: 2020-03-04

Lead Sponsor: University of California, San Diego

Target Recruit Count: 1034

Registration Number: NCT02083770

Locations: 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States

Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent

Not Applicable

Completed

Conditions: Meniere's Disease

Interventions: Drug: Magnevist (gadopentetate dimeglumine)

First Posted Date: 2014-03-06

Last Posted Date: 2016-02-12

Lead Sponsor: University of California, San Diego

Target Recruit Count: 6

Registration Number: NCT02080312

Locations: 🇺🇸
UC San Diego Health System, San Diego, California, United States

Promoting Child Inhibitory Control Skills Around Food

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: CHild Inhibitory Control (CHIC) Play
Behavioral: Attention control

First Posted Date: 2014-03-04

Last Posted Date: 2016-02-03

Lead Sponsor: University of California, San Diego

Target Recruit Count: 72

Registration Number: NCT02077387

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Dietary Supplement: CocoaVia

First Posted Date: 2014-02-20

Last Posted Date: 2015-06-03

Lead Sponsor: University of California, San Diego

Target Recruit Count: 7

Registration Number: NCT02068040

Locations: 🇺🇸
University of California, San Diego, La Jolla, California, United States

Sentinel Lymph Node Mapping Post-Injection Site Pain

Completed

Conditions: Breast Cancer

Interventions: Drug: Sulfur Colloid
Drug: Tilmanocept

First Posted Date: 2014-02-17

Last Posted Date: 2019-08-14

Lead Sponsor: University of California, San Diego

Target Recruit Count: 52

Registration Number: NCT02065232

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States

The Effect of Surfactants on the Bacterial Composition of the Layers of the Skin

Not Applicable

Withdrawn

Conditions: Focus: Healthy Skin Microbiome

Interventions: Other: Soap 300000027003
Other: Soap 300000029240

First Posted Date: 2014-02-06

Last Posted Date: 2018-08-22

Lead Sponsor: University of California, San Diego

Registration Number: NCT02057055

Locations: 🇺🇸
University of California San Diego Division of Dermatology, San Diego, California, United States

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

Phase 2

Terminated

Conditions: Acute Lymphocytic Leukemia
Adult Lymphoblastic Lymphoma

Interventions: Drug: DNR
Drug: VCR
Drug: PEG-asp
Drug: CTX
Drug: Prednisone
Drug: Liposomal AraC
Drug: MTX
Drug: LCV
Drug: AraC
Drug: Etoposide
Drug: Dasatinib
Drug: Rituximab
Drug: Hydrocortisone

First Posted Date: 2014-01-23

Last Posted Date: 2022-05-02

Lead Sponsor: University of California, San Diego

Target Recruit Count: 31

Registration Number: NCT02043587

Locations: 🇺🇸
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center, La Jolla, California, United States
🇺🇸
Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA, Los Angeles, California, United States
🇺🇸
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

and more 1 locations

Treatment of Hemodialysis Catheter-Related Bacteremia

Phase 2

Withdrawn

Conditions: Hemodialysis Catheter-related Bacteremia

Interventions: Drug: tigecycline, N-acetylcysteine, heparin combination
Device: guide-wire exchange

First Posted Date: 2014-01-20

Last Posted Date: 2015-10-08

Lead Sponsor: University of California, San Diego

Registration Number: NCT02040818

Locations: 🇺🇸
University of California, San Diego Medical Center, San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy